Results for tag: "Zortress"

Zortress is a type of breast cancer drug used to treat hormone receptor-positive, HER2-negative metastatic breast cancer. It is a type of aromatase inhibitor, which works by blocking the production of estrogen in the body. This helps to slow the growth of certain types of breast cancer cells. Zortress is typically used in combination with other drugs, such as fulvestrant, to treat metastatic breast cancer. It is also used to reduce the risk of recurrence in postmenopausal women who have already been treated for early-stage breast cancer. The Zortress market is a rapidly growing segment of the breast cancer drug market. It is a highly competitive market, with many companies offering different formulations of the drug. Companies in the Zortress market include Pfizer, Novartis, AstraZeneca, and Eli Lilly. These companies are all actively researching and developing new formulations of the drug, as well as exploring new uses for it. Show Less Read more